Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Assets Average (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Assets Average for 14 consecutive years, with $280.9 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 23.28% to $280.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $280.9 million through Dec 2025, down 23.28% year-over-year, with the annual reading at $304.0 million for FY2025, 38.52% up from the prior year.
  • Assets Average hit $280.9 million in Q4 2025 for Perspective Therapeutics, down from $302.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $388.5 million in Q3 2024 to a low of $43.4 million in Q1 2021.
  • Historically, Assets Average has averaged $172.9 million across 5 years, with a median of $109.8 million in 2023.
  • Biggest five-year swings in Assets Average: surged 731.89% in 2021 and later decreased 23.28% in 2025.
  • Year by year, Assets Average stood at $68.0 million in 2021, then fell by 11.28% to $60.3 million in 2022, then surged by 72.77% to $104.2 million in 2023, then soared by 251.35% to $366.1 million in 2024, then decreased by 23.28% to $280.9 million in 2025.
  • Business Quant data shows Assets Average for CATX at $280.9 million in Q4 2025, $302.8 million in Q3 2025, and $320.0 million in Q2 2025.